Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $227.38 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $144.63 | 8 | $0 (2023) |
| ABBVIE INC. | $56.29 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $26.46 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $142.14 | 7 | Novo Nordisk Inc ($95.95) |
| 2022 | $85.24 | 5 | Novo Nordisk Inc ($48.68) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.64 | General |
| 08/30/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: PSYCHIATRY | ||||||
| 06/14/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Diabetes | ||||||
| 03/21/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Obesity | ||||||
| 02/08/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Obesity | ||||||
| 11/30/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Obesity | ||||||
| 08/31/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.89 | General |
| 06/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 219 | 260 | $49,742 | $15,262 |
| 2022 | 6 | 166 | 179 | $38,864 | $12,057 |
| 2021 | 7 | 167 | 182 | $45,796 | $13,974 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 104 | $22,360 | $7,355 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 30 | $10,590 | $2,794 | 26.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 21 | 21 | $1,470 | $1,134 | 77.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $3,025 | $1,118 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,828 | $1,087 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $2,808 | $755.68 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,816 | $733.10 | 26.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $1,290 | $131.52 | 10.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 11 | $1,023 | $92.50 | 9.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 28 | $532.00 | $61.60 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 49 | $10,535 | $3,639 | 34.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 36 | $12,708 | $3,626 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $10,788 | $2,914 | 27.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 31 | 31 | $2,170 | $940.54 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $2,340 | $898.87 | 38.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 17 | $323.00 | $37.50 | 11.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $13,920 | $4,269 | 30.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $10,230 | $3,068 | 30.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 39 | $8,385 | $2,778 | 33.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 22 | $7,766 | $2,502 | 32.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 18 | 18 | $3,924 | $949.31 | 24.2% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 11 | 22 | $1,210 | $364.10 | 30.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 19 | 19 | $361.00 | $42.75 | 11.8% |
About Paige Luck, PA-C
Paige Luck, PA-C is a Physician Assistant healthcare provider based in Zebulon, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2020. The National Provider Identifier (NPI) number assigned to this provider is 1437789807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paige Luck, PA-C has received a total of $227.38 in payments from pharmaceutical and medical device companies, with $142.14 received in 2023. These payments were reported across 12 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($227.38).
As a Medicare-enrolled provider, Luck has provided services to 552 Medicare beneficiaries, totaling 621 services with total Medicare billing of $41,292. Data is available for 3 years (2021–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Zebulon, NC
- Active Since 01/24/2020
- Last Updated 02/05/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1437789807
Products in Payments
- Saxenda (Drug) $53.16
- Ozempic (Drug) $45.75
- UBRELVY (Drug) $36.56
- REXULTI (Drug) $26.46
- QULIPTA (Drug) $19.73
- Rybelsus (Drug) $14.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Zebulon
Mrs. Victoria Harris, Pa-C, PA-C
Physician Assistant — Payments: $1,380
Anais Olivero, Pa-C, PA-C
Physician Assistant — Payments: $487.25
Matthew Pace, Pa-C, PA-C
Physician Assistant — Payments: $41.42
Ms. Zandi Fennell, Pa-C, PA-C
Physician Assistant
Cassidy Prentice, Pac, PAC
Physician Assistant